A high-conviction, contrarian investor heavily utilizing AI for deal sourcing and backing AI-native SaaS and health platforms across Africa (e.g., Reliance Health).
About P1 Ventures
P1 Ventures is a high-conviction pan-African early-stage venture firm headquartered in Dakar with an explicit AI-driven thesis, both in terms of deal sourcing methodology and portfolio construction. The verified portfolio includes Reliance Health, the Nigerian-Egyptian employer-healthcare platform that has scaled meaningfully across both markets, alongside other AI-touched portfolio bets in fintech and SaaS such as Mindjoy, Lua AI, and BetterAuth. Stage focus is seed and Series A with checks in the $1M to $5M range, and AI is a primary focus. The fund closed its second fund at $35M in 2024, which is a meaningful scale for an African-focused fund. The right founder for P1 is an African or African-diaspora operator building an AI-native or AI-enabled healthcare, fintech, or SaaS business with credible market wedge in Nigeria, Egypt, Kenya, South Africa, or wider African markets. The wrong founder is a deep medtech or therapeutics team, a non-African founder using the continent only as a satellite, or a hyper-local single-country business without continental scale ambition. Intro paths run through Dakar, Lagos, Cairo, Nairobi, and Cape Town operator networks, frequent co-investors and follow-on partners including Future Africa, 4DX Ventures, Madica, Ventures Platform, LoftyInc, Partech Africa, TLcom, Quona Capital, and global investors with Africa exposure such as General Catalyst and Tiger Global, and through P1’s own portfolio CEOs many of whom are publicly active. Cold outreach is read by the team given P1’s data-driven sourcing approach but warm intros from credible African operators remain the highest-conversion path. In the pitch, lead with the AI architecture and what is genuinely defensible about your data moat, since P1’s diligence on AI is sharper than most African funds and weak claims will be priced down quickly. Show real customer evidence including cohort retention and unit economics in local currencies with realistic FX assumptions, and a credible cross-border execution story across at least two African markets. Be specific about NAFDAC, EDA, KMPDC, HPCSA, and analogous regulatory regimes, and about the data infrastructure realities that shape what AI is actually possible. Caveats include the persistent challenge of follow-on Series B and beyond capital for African startups, the FX volatility that has reshaped unit economics in primary markets, and the increasingly competitive landscape for African AI-native deals. For credible African operators with strong AI and execution credentials, P1 is one of the most thesis-aligned regional partners with an actual conviction-based investment style.
Founder reviews
Other portfolio companies
Companies in P1 Ventures's portfolio not currently in our directory.
- Yassir
- Money Fellows
- Reliance Health
- Chari
Team
Pitch / review this investor
Have you raised from P1 Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).